21 Jan Risk of Endophthalmitis from Aflibercept-Related Sterile Intraocular Inflammation

MedicalResearch.com Interview with:
Pravin U. Dugel MD
Managing Partner, Retinal Consultants of Arizona Phoenix AZ
Clinical Professor  USC Eye Institute
Keck School of Medicine  Los Angeles CA

Medical Research: What is the background for this study? What are the main findings?

Dr. Dugel: Endophthalmitis is one of the most feared complications in ophthalmology. It is potentially blinding. All retina specialists should be aware of any data involving this complication. This is valuable information that has direct patient care implications. However, it is equally important to distinguish definitive data from hypothesis building data. This is the latter, not the former. Further investigations will either confirm or refute this … But such investigations are warranted.

Medical Research: What should clinicians and patients take away from your report?

Dr. Dugel: It is important to remember that this is a summary of a voluntarily reported database. Therefore, it is not a definitive study. Nonetheless, the relative number of cases, the cluster of patients and the existence of other supportive  Medicare data-based studies, suggests that this issue warrants further investigation.

Citation:

[wysija_form id=”1″]

Last Updated on January 21, 2015 by Marie Benz MD FAAD